Evidence map›Paper›PMID 41096099›Full record

ArticleJournal of clinical medicine2025

Elevated Serum Protease 3 Antineutrophil Cytoplasmic Antibody in Mesalazine-Intolerant Ulcerative Colitis: A Potential Diagnostic Biomarker.

Yuhei Oyama, Takashi Taida, Yoshiki Matsubara, Tomomi Ozaki, Takuya Ohashi, Toshiyuki Ito, Shohei Mukai, Nobuaki Shu, Yushi Koshibu, Yusuke Ozeki and 15 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Yuhei OyamaDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.ORCID 0000-0001-9536-6678
Takashi TaidaDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.ORCID 0000-0002-1870-1863
Yoshiki MatsubaraDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.
Tomomi OzakiDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.
Takuya OhashiDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.
Toshiyuki ItoDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.
Shohei MukaiDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.
Nobuaki ShuDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.
Yushi KoshibuDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.
Yusuke OzekiDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.
Makoto FuruyaDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.
Yukiyo MamiyaDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.
Hayato NakazawaDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.
Ryosuke HorioDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.
Chihiro GotoDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.
Satsuki TakahashiDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.
Akane KurosugiDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.
Michiko SonodaDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.
Tatsuya KanekoDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.
Tsubasa IshikawaDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.
Yuki OhtaDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.ORCID 0000-0003-3691-8115
Kenichiro OkimotoDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.
Keiko SaitoDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.ORCID 0000-0003-4341-8135
Tomoaki MatsumuraDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.
Jun KatoDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

mesalazine intoleranceproteinase 3 antineutrophil cytoplasmic antibodyulcerative colitis

Identifiers

PMID41096099
PMCPMC12524825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.